Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2010
11/18/2010US20100291242 Antagonist against tolerance to anticancer drugs
11/18/2010US20100291238 Appetite suppressant product and method
11/18/2010US20100291236 Osmium compounds
11/18/2010US20100291234 Compositions and methods for treating inflammatory arthritis
11/18/2010US20100291226 Pharmaceutical Formulations Based on Apolar and Polar Lipids for Ophthalmic Use
11/18/2010US20100291225 Stabilized Sustained Release Composition of Bupropion Hydrochloride and Process For Preparing the Same
11/18/2010US20100291222 Antioxidant nanosphere comprising [1,2]-dithiolane moieties
11/18/2010US20100291221 Method of administering dose-sparing amounts of formoterol fumarate-budesonide combination particles by inhalation
11/18/2010US20100291220 Antibiotic formulation and method of treatment
11/18/2010US20100291218 Immunomodulatory compositions, formulations, and methods for use thereof
11/18/2010US20100291217 Pharmaceutical compositions
11/18/2010US20100291216 Pharmaceutical compositions
11/18/2010US20100291209 Organic compounds
11/18/2010US20100291208 Controlled porous osmotic pump tablets of high permeable drugs and the preparation process thereof
11/18/2010US20100291207 Pharmaceutical formulation comprising ezetimibe
11/18/2010US20100291206 Oral dosage form
11/18/2010US20100291205 Pharmaceutical compositions and methods for mitigating risk of alcohol induced dose dumping or drug abuse
11/18/2010US20100291204 Combination of a long-acting hypnotic agent and a short-acting hypnotic agent and therapeutic use thereof
11/18/2010US20100291203 Opioid Agonist/Antagonist Combinations
11/18/2010US20100291201 Coated pharmaceutical capsule dosage form
11/18/2010US20100291199 Compositions and Methods For The Treatment and Prevention of Disease
11/18/2010US20100291198 Compositions of phytosterols with enhanced bioavailability
11/18/2010US20100291197 hot melt-filled soft capsules
11/18/2010US20100291195 Topical delivery of l-arginine to cause beneficial effects
11/18/2010US20100291194 Compositions and Methods for Inhibiting Expression of a Mutant Gene
11/18/2010US20100291193 Immunogenic compositions comprising progastrin and uses thereof
11/18/2010US20100291191 Tunable sustained release of a sparingly soluble hydrophobic therapeutic agent from a hydrogel matrix
11/18/2010US20100291188 Periostin Inhibitory Compositions for Myocardial Regeneration, Methods of Delivery, and Methods of Using Same
11/18/2010US20100291186 Transdermal Administration of Tamsulosin
11/18/2010US20100291185 Theritol phosphates, salts thereof and methods of use
11/18/2010US20100291182 Drug-Loaded Fibers
11/18/2010US20100291181 Therapeutic devices for patterned cell growth
11/18/2010US20100291180 Nerve guidance tubes
11/18/2010US20100291173 Method of improving renal function
11/18/2010US20100291171 Hyaluronic acid derivatives obtained via "click chemistry" crosslinking
11/18/2010US20100291170 Novel therapies for chronic renal failure
11/18/2010US20100291169 Polyelectrolyte Complex for Imparting Antimicrobial Properties to a Substrate
11/18/2010US20100291168 Antimicrobial formulations comprising a combination of a pyridine thiol and a bis-quinolinium salt
11/18/2010US20100291161 Cellulose powder
11/18/2010US20100291160 Pharmaceutical system for trans-membrane delivery
11/18/2010US20100291158 Sustained release oral composition of an antipsychotic agent
11/18/2010US20100291157 Composition for headache treatment
11/18/2010US20100291151 1-methylpyrazole modulators of substance p, calcitonin gene-related peptide, adrenergic receptor, and/or 5-ht receptor
11/18/2010US20100291143 Inhibition of HIV and SHIV Replication with Antisense Interleukin-4
11/18/2010US20100291139 Recombinant mva virus and the use thereof
11/18/2010US20100291120 Peptides regulating the surface expression of the t cell receptor
11/18/2010US20100291118 Class of Gamma Delta T Cells Activators and Use Thereof
11/18/2010US20100291116 Microparticle comprising cross-linked polymer
11/18/2010US20100291112 Recombinant, Single-Chain, Trivalent Tri-Specific or Bi-Specific Antibody Derivatives
11/18/2010US20100291099 Novel 27411, 23413, 22438, 23553, 25278, 26212, narc sc1, narc 10a, narc 1, narc 12, narc 13, narc17, narc 25, narc 3, narc 4, narc 7, narc 8, narc 11, narc 14a, narc 15, narc 16, narc 19, narc 20, narc 26, narc 27, narc 28, narc 30, narc 5, narc 6, narc 9, narc 10c, narc 8b, narc 9, narc2a, narc 16b, narc 1c, narc 1a, narc 25, 86604 and 32222 molecules and uses therefor
11/18/2010US20100291098 Diabetic nephropathy therapies
11/18/2010US20100291091 Cancer associated gene ly6k
11/18/2010US20100291090 Prion Protein as a Receptor for Amyloid-Beta Oligomers
11/18/2010US20100291089 Ligand of regulating immune response, and use thereof in treating an immune response-related disease
11/18/2010US20100291086 Use of estrogen and androgen binding proteins in methods and compositions for treating gynaecological cancers
11/18/2010US20100291084 Use of il-23 antagonists for treatment of infection
11/18/2010US20100291074 Cyclophilin d-amyloid beta interaction potentiates mitochondrial dysfunction in a transgenic mouse model of alzheimer's disease
11/18/2010US20100291069 Methods of treating a diabetic embryopathy
11/18/2010US20100291061 Process for making oligopeptides
11/18/2010US20100291057 Composition for Reducing Oxidative Stress and/or Side Effects Occurring During Cancer Chemotherapy or Improving Nutritional Status During Cancer Chemotherapy
11/18/2010US20100291056 Pharmaceutical Compositions Comprising Prasugrel and Cyclodextrin Derivatives and Methods of Making and Using the Same
11/18/2010US20100291055 Surgical hydrogel
11/18/2010US20100291053 Inflammatory Disease Treatment
11/18/2010US20100291043 Il-12 immunotherapy for cancer
11/18/2010US20100291036 Compositions and methods for modulating vascular endothelial growth factor c (vegf-c) expression
11/18/2010US20100291032 Compositions and methods for the identification of inhibitors of retroviral infection
11/18/2010US20100291031 Bicyclic nucleosides and nucleotides as therapeutic agents
11/18/2010US20100291028 Use of il-18 inhibitors for treatment and/or prevention of peripheral vascular diseases
11/18/2010US20100291027 Hyaluronic acid (ha) injection vehicle
11/18/2010US20100291026 Piperidine inhibitors of janus kinase 3
11/18/2010US20100291025 Indazole inhibitors of tyrosine kinase
11/18/2010US20100291021 Aliphatic prodrug linker
11/18/2010US20100291020 Novel compounds as dipeptidyl peptidase iv (dpp iv) inhibitors
11/18/2010US20100291019 Methods of Using Ophthalmic Compositions Comprising Povidone-Iodine
11/18/2010US20100291009 Preparation comprising chroman-2-one derivatives
11/18/2010US20100291005 Use of trans-pellitorin as flavor substance
11/18/2010US20100291004 Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof
11/18/2010US20100291003 Histone deacetylase inhibitors
11/18/2010US20100291002 Combination comprising pyrrolidone-5-carboxylic acid and at least one compound from citrulline, arginine and asparagine, and use thereof in the treatment of atopic dermatitis
11/18/2010US20100290998 Methods of preventing ischemic injury using peripheral nociceptive stimulation
11/18/2010US20100290994 O-Methylated Rapamycin Derivatives For Alleviation And Inhibition Of Lymphoproliferative Disorders
11/18/2010US20100290992 Nanoparticle nucleic acid binding compound conjugates forming i-motifs
11/18/2010US20100290990 Method for preparing a marked purine derivative, said derivative and uses thereof
11/18/2010US20100290989 Compositions affecting hyaluronic acid mediated activity
11/18/2010US20100290986 Therapeutic use of diaminophenothiazines
11/18/2010US20100290983 Compositions and Methods for Drug Delivery
11/18/2010US20100290982 Solid in oil/water emulsion-diffusion-evaporation formulation for preparing curcumin-loaded plga nanoparticles
11/18/2010US20100288665 Therapeutic formulations for the treatment of cold and flu-like symptoms
11/18/2010US20100288276 Compositions for treating parkinson's disease
11/18/2010DE202010012255U1 Nasenspray Nasal spray
11/18/2010DE202010012041U1 Zubereitung zur Nagelpflege Preparation for nail care
11/18/2010DE102009021592A1 ASLV-Vektorsystem ASLV-vector system
11/18/2010DE102009021372A1 Phosphatfreie pharmazeutische Zusammensetzung zur Glaukombehandlung Phosphate-free pharmaceutical composition for the treatment of glaucoma
11/18/2010DE102009020888A1 Schmelztablette, enthaltend ein Vardenafil-Salz Melting tablet containing a vardenafil salt
11/18/2010CA2799569A1 Stable functional beverage compositions and processes for making same
11/18/2010CA2799087A1 Perhexiline for use in the treatment of hypertrophic cardiomyopathy (hcm)
11/18/2010CA2763347A1 Methods for treatment of disease using an epimetabolic shifter (coenzyme q10)
11/18/2010CA2763336A1 Methods for treatment of metabolic disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
11/18/2010CA2762107A1 Sublingual dexmedetomidine compositions and methods of use thereof
11/18/2010CA2762036A1 Inhibitors of human immunodeficiency virus replication
1 ... 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 ... 7860